November 15, 2015
1 min read
Save

New platform offers courses, strategies for diabetes management

A new, interactive diabetes education tool designed for patients with type 2 diabetes and their family members will help to foster better management of the disease and dispel common diabetes myths, according to a press release from the Hormone Health Network.

An expert panel convened by the Hormone Health Network, an arm of the Endocrine Society, developed the free online platform, called D.A.I.L.Y (Diabetes Awareness Information for Loved Ones and You). The platform offers a selection of courses users can take on four topics, including healthy behaviors and type 2 diabetes myths, type 2 diabetes treatments, healthy eating and BMI calculator, and physical activity and exercise.

“The diabetes D.A.I.L.Y. course fills an unmet need for people with type 2 diabetes and their caregivers and loved ones with a unique, one-stop resource that offers easy-to-use tools that work on any mobile platform and is accessible anytime, anywhere,” Henry Anhalt, DO, committee chair of the Hormone Health Network, said in a press release. “D.A.I.L.Y. is a trusted resource to help patients and loved ones to build a collaborative network with their medical experts to support in the management of their type 2 diabetes.”

Each course includes videos, fact sheets, patient stories, case studies and peer-to-peer resources, allowing caregivers and family members to share information and have access to experts.

Sean Vasaitis, PhD, assistant professor of pharmaceutical sciences at the University of Maryland, Eastern Shore, and a member of the D.A.I.L.Y. expert panel, said the tool helps the patient and their family become more involved and more active in diabetes management.

“The program is unique in that it provides resources tailored to the individual patient’s needs and can be shared with health care professionals to help make more informed medical decisions on behalf of the patient,” Vasaitis said in a press release.

The tool is available at www.dailydiabetes.org. Boehringer Ingelheim, Lilly Diabetes Alliance and Janssen Pharmaceuticals provided partial funding for the platform.